Evidence map›Paper›PMID 33500254›Full record

ArticleDiabetes2021

Loss of MANF Causes Childhood-Onset Syndromic Diabetes Due to Increased Endoplasmic Reticulum Stress.

Hossam Montaser, Kashyap A Patel, Diego Balboa, Hazem Ibrahim, Väinö Lithovius, Anna Näätänen, Vikash Chandra, Korcan Demir, Sezer Acar, Tawfeg Ben-Omran and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Neuroplastin-55 is a receptor of Manf and protects against diet-induced obesity by promoting adipose browning.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  9. Review
  10. Review
  11. Article
  12. Neonatal and Syndromic Forms of Diabetes.Current diabetes reports · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Monogenic diabetes.Nature reviews. Disease primers · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 5 countries.

Hossam MontaserStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Kashyap A PatelInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, U.K. timo.otonkoski@helsinki.fi k.a.patel@exeter.ac.uk.ORCID 0000-0002-9240-8104
Diego BalboaBioinformatics and Genomics Program, Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain.
Hazem IbrahimStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Väinö LithoviusStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Anna NäätänenStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Vikash ChandraStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Korcan DemirDepartment of Pediatric Endocrinology, Dokuz Eylül University, Izmir, Turkey.
Sezer AcarDepartment of Pediatric Endocrinology, Dokuz Eylül University, Izmir, Turkey.
Tawfeg Ben-OmranSection of Clinical and Metabolic Genetics, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar.
Kevin ColcloughDepartment of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Exeter, U.K.
Jonathan M LockeInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, U.K.ORCID 0000-0001-9516-5251
Matthew WakelingInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, U.K.
Maria LindahlResearch Program in Developmental Biology, Institute of Biotechnology, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-5674-8830
Andrew T HattersleyInstitute of Biomedical and Clinical Science, College of Medicine and Health, University of Exeter, Exeter, U.K.ORCID 0000-0001-5620-473X
Jonna Saarimäki-VireStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Timo OtonkoskiStem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland timo.otonkoski@helsinki.fi k.a.patel@exeter.ac.uk.ORCID 0000-0001-9190-2496
University of Helsinki · FIUniversity of Exeter · GBDokuz Eylül University · TRCentre for Genomic Regulation · ESRoyal Devon & Exeter NHS Foundation Trust · GBWeill Cornell Medical College in Qatar · QA

Funding

Wellcome Trust 098395Wellcome Trust 110082Wellcome Trust 219606
6 · The paper itself

Abstract

Mesencephalic astrocyte-derived neurotrophic factor (MANF) is an endoplasmic reticulum (ER)-resident protein that plays a crucial role in attenuating ER stress responses. Although MANF is indispensable for the survival and function of mouse β-cells, its precise role in human β-cell development and function is unknown. In this study, we show that lack of MANF in humans results in diabetes due to increased ER stress, leading to impaired β-cell function. We identified two patients from different families with childhood diabetes and a neurodevelopmental disorder associated with homozygous loss-of-function mutations in the

Indexed as

Blotting, WesternEndoplasmic Reticulum StressEnzyme-Linked Immunosorbent AssayFemaleFlow CytometryGene EditingGlucose Tolerance TestHumansImmunohistochemistryMaleMutationNerve Growth FactorsReal-Time Polymerase Chain ReactionStreptozocinMANF protein, humanNerve Growth FactorsStreptozocin

Identifiers

PMID33500254
PMCPMC7610619
OpenAlexW3124271685

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.